Michael Conzelmann

651 total citations
14 papers, 500 citations indexed

About

Michael Conzelmann is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Michael Conzelmann has authored 14 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 5 papers in Immunology. Recurrent topics in Michael Conzelmann's work include Genetic factors in colorectal cancer (5 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Michael Conzelmann is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Michael Conzelmann collaborates with scholars based in Germany and Australia. Michael Conzelmann's co-authors include Martin R. Berger, Thomas Luft, Anthony D. Ho, Michael Heß, Peter Dreger, Ute Hegenbart, Axel Benner, Christine S. Falk, Sascha Dietrich and Frank Neumann and has published in prestigious journals such as Blood, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Michael Conzelmann

14 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Conzelmann Germany 10 174 160 144 120 64 14 500
Emma Ross United Kingdom 7 272 1.6× 136 0.8× 108 0.8× 100 0.8× 33 0.5× 8 729
Masayasu Kitano Japan 13 119 0.7× 156 1.0× 102 0.7× 288 2.4× 31 0.5× 33 589
Hiroaki Tanaka Japan 11 193 1.1× 91 0.6× 186 1.3× 82 0.7× 33 0.5× 55 540
Silvana Compasso Italy 10 132 0.8× 115 0.7× 103 0.7× 161 1.3× 28 0.4× 10 489
Toni Valković Croatia 13 214 1.2× 110 0.7× 335 2.3× 194 1.6× 75 1.2× 42 586
Shihui Ma China 15 201 1.2× 292 1.8× 92 0.6× 215 1.8× 80 1.3× 33 629
Kishiko Nakamura Japan 13 107 0.6× 123 0.8× 114 0.8× 118 1.0× 29 0.5× 18 440
Wang Cy China 9 170 1.0× 63 0.4× 106 0.7× 179 1.5× 58 0.9× 36 568
Cuihong Wei Canada 8 89 0.5× 90 0.6× 147 1.0× 118 1.0× 57 0.9× 16 368
Francis Bonnefoy France 15 408 2.3× 86 0.5× 82 0.6× 152 1.3× 45 0.7× 29 616

Countries citing papers authored by Michael Conzelmann

Since Specialization
Citations

This map shows the geographic impact of Michael Conzelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Conzelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Conzelmann more than expected).

Fields of papers citing papers by Michael Conzelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Conzelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Conzelmann. The network helps show where Michael Conzelmann may publish in the future.

Co-authorship network of co-authors of Michael Conzelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Conzelmann. A scholar is included among the top collaborators of Michael Conzelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Conzelmann. Michael Conzelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Wagner, Andreas H., Michael Conzelmann, Thomas Giese, et al.. (2015). JAK1/STAT3 activation directly inhibits IL-12 production in dendritic cells by preventing CDK9/P-TEFb recruitment to the p35 promoter. Biochemical Pharmacology. 96(1). 52–64. 18 indexed citations
3.
Luft, Thomas, Sascha Dietrich, Christine S. Falk, et al.. (2011). Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system. Blood. 118(6). 1685–1692. 159 indexed citations
4.
Conzelmann, Michael, Andreas H. Wagner, Anke Hildebrandt, et al.. (2010). IFN-γ activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 production. Biochemical Pharmacology. 80(12). 2074–2086. 21 indexed citations
5.
Conzelmann, Michael, Michael Heß, Annika Zota, et al.. (2008). The Second Signal in Antigen-Presenting Cells: Complementary JAK1/JAK2 and CD40 Signalling Mediate Pro-Inflammatory Activation.. Blood. 112(11). 1261–1261. 1 indexed citations
6.
Luft, Thomas, Michael Conzelmann, Axel Benner, et al.. (2007). Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease. Blood. 110(13). 4535–4542. 79 indexed citations
7.
Conzelmann, Michael, Michael Heß, Thomas Giese, et al.. (2007). Complementary JAK/STAT Signalling Is Required for the Pro-Inflammatory Effects of CD40 Ligation: Differential Effects in Human Myeloid and B Cells.. Blood. 110(11). 2413–2413. 1 indexed citations
8.
Conzelmann, Michael, Eugene Maraskovsky, Michael Heß, et al.. (2006). GSK-3 mediates differentiation and activation of proinflammatory dendritic cells. Blood. 109(4). 1584–1592. 90 indexed citations
9.
Conzelmann, Michael, et al.. (2005). Detection of disseminated tumour cells in the liver of cancer patients. European Journal of Surgical Oncology. 31(9). 977–985. 16 indexed citations
10.
Conzelmann, Michael, et al.. (2004). Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use?. International Journal of Colorectal Disease. 20(2). 137–146. 26 indexed citations
12.
Conzelmann, Michael, et al.. (2004). Detection of disseminated tumour cells in the liver of colorectal cancer patients. European Journal of Surgical Oncology. 31(1). 38–44. 9 indexed citations
13.
Conzelmann, Michael, et al.. (2004). K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.. PubMed. 24(6). 1537–44. 14 indexed citations
14.
Conzelmann, Michael, et al.. (2003). Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients. International Journal of Cancer. 107(4). 617–628. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026